+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Drugs Market Research Reports

From
Antidiarrheals Global Market Report 2024 - Product Thumbnail Image

Antidiarrheals Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
From
Geriatric Medicines - Global Strategic Business Report - Product Thumbnail Image

Geriatric Medicines - Global Strategic Business Report

  • Report
  • November 2024
  • 304 Pages
  • Global
From
Digestive Health Products - Global Strategic Business Report - Product Thumbnail Image

Digestive Health Products - Global Strategic Business Report

  • Report
  • November 2024
  • 297 Pages
  • Global
From
Proton Pump Inhibitors (PPIs) - Global Strategic Business Report - Product Thumbnail Image

Proton Pump Inhibitors (PPIs) - Global Strategic Business Report

  • Report
  • November 2024
  • 268 Pages
  • Global
From
Infectious Enteritis Treatment - Global Strategic Business Report - Product Thumbnail Image

Infectious Enteritis Treatment - Global Strategic Business Report

  • Report
  • November 2024
  • 276 Pages
  • Global
From
Antacids - Global Strategic Business Report - Product Thumbnail Image

Antacids - Global Strategic Business Report

  • Report
  • November 2024
  • 486 Pages
  • Global
From
Splenomegaly Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Splenomegaly Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 169 Pages
  • Global
From
Gastroparesis Drugs - Global Strategic Business Report - Product Thumbnail Image

Gastroparesis Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 197 Pages
  • Global
From
Peptic Ulcer Drugs - Global Strategic Business Report - Product Thumbnail Image

Peptic Ulcer Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 196 Pages
  • Global
From
Short Bowel Syndrome (SBS) - Global Strategic Business Report - Product Thumbnail Image

Short Bowel Syndrome (SBS) - Global Strategic Business Report

  • Report
  • November 2024
  • 194 Pages
  • Global
From
Ulcerative Colitis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Ulcerative Colitis Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 181 Pages
  • Global
From
Anal Fistula Treatment - Global Strategic Business Report - Product Thumbnail Image

Anal Fistula Treatment - Global Strategic Business Report

  • Report
  • November 2024
  • 194 Pages
  • Global
From
Artificial Saliva - Global Strategic Business Report - Product Thumbnail Image

Artificial Saliva - Global Strategic Business Report

  • Report
  • November 2024
  • 182 Pages
  • Global
From
From
Magnesium Oxide Nanopowder - Global Strategic Business Report - Product Thumbnail Image

Magnesium Oxide Nanopowder - Global Strategic Business Report

  • Report
  • November 2024
  • 196 Pages
  • Global
From
Betaine - Global Strategic Business Report - Product Thumbnail Image

Betaine - Global Strategic Business Report

  • Report
  • November 2024
  • 194 Pages
  • Global
From
Antiemetic Drugs - Global Strategic Business Report - Product Thumbnail Image

Antiemetic Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 179 Pages
  • Global
From
From
Loading Indicator

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists. The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more